Lion Point Capital, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$16.7M
Q ending 2026-03-31
Prior quarter
$19.3M
Q ending 2025-12-31
Change
-13.4% QoQ · +6.7% YoY
Positions
35
reported holdings
Largest positions
All 35 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Praxis Precision Medicines I | PRAX | Shares | $1.4M | 4K |
| Moonlake Immunotherapeutics | MLTX | Shares | $1.3M | 68K |
| Royalty Pharma Plc | Shares | $1.0M | 21K | |
| Milestone Pharmaceuticals In | MIST | Shares | $976K | 820K |
| Geron Corp | GERN | Shares | $861K | 578K |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $841K | 36K |
| Ardelyx Inc | ARDX | Shares | $771K | 129K |
| Fennec Pharmaceuticals Inc | FENC | Shares | $691K | 112K |
| Benitec Biopharma Inc | BNTC | Shares | $660K | 62K |
| Sarepta Therapeutics Inc | SRPT | Shares | $620K | 29K |
| Disc Medicine Inc | IRON | Shares | $518K | 8K |
| Cue Biopharma Inc | CUE1EUR | Shares | $506K | 2.2M |
| Compass Pathways Plc | CMPS | Shares | $442K | 80K |
| Biohaven Ltd | Shares | $437K | 52K | |
| Lantheus Hldgs Inc | LNTH | Shares | $417K | 6K |
| Jasper Therapeutics Inc | JSPR | Shares | $407K | 465K |
| Humacyte Inc | HUMA | Shares | $394K | 650K |
| Viatris Inc | VTRS | Shares | $374K | 28K |
| Kura Oncology Inc | KURA | Shares | $374K | 46K |
| Bridgebio Pharma Inc | BBIO | Shares | $371K | 5K |
| Dyne Therapeutics Inc | DYN | Shares | $326K | 18K |
| Rocket Pharmaceuticals Inc | RCKT | Shares | $308K | 86K |
| Pacira Biosciences Inc | PCRX | Shares | $305K | 14K |
| Edgewise Therapeutics Inc | EWTX | Shares | $287K | 9K |
| Mineralys Therapeutics Inc | MLYS | Shares | $284K | 11K |
| Seres Therapeutics Inc | MCRB | Shares | $280K | 32K |
| Janux Therapeutics Inc | JANX | Shares | $264K | 19K |
| Uniqure Nv | Shares | $240K | 15K | |
| Regenxbio Inc | RGNX | Shares | $223K | 27K |
| Azenta Inc | AZTA | Shares | $205K | 10K |
| Innoviva Inc | INVA | Shares | $191K | 8K |
| Gh Research Plc | Shares | $143K | 10K | |
| Arcutis Biotherapeutics Inc | ARQT | Shares | $124K | 5K |
| Innate Pharma S A | IPHA | Shares | $104K | 81K |
| Spruce Biosciences Inc | SPRB | Shares | $65K | 1K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.